Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Spring Cleaning for Financials: 2 to Sell, 2 to Buy

By Jeff Reeves
There's a big difference between which companies to keep and which to dump. Here's where these four names fall.

Starbucks Declares War on Jamba Juice

By Lawrence Meyers, InvestorPlace Contributor
Yes, the move into juice will grievously harm Jamba, but it will also be a disaster for Starbucks.

Gold, Silver Jump Amid Lower U.S. Home Sales

By Andrew Burger, InvestorPlace Contributor
Precious metals were showing healthy gains Friday morning to close out a down week, recovering somewhat from recent losses.

Starbucks’ Schultz Is Still Dreaming Big

By Susan J. Aluise, Aviation, Auto & Transportation Writer
Howard Schultz has big plans to restore Starbucks' core "customer experience" while innovating in juice and energy drinks.

Under Armour’s Game Plan Is Playing Out Well

By Kyle Woodley, Senior Investing Editor, Kiplinger
It's growing wildly -- and very profitably. The future also looks quite promising. But, oh, that pricey stock. Still, here's why UA could help your team.

Lions Gate: ‘Hunger Games’ Is Just the Start

By Louis Navellier, Editor, Growth Investor
Lions Gate has been a fast-moving stock due to the explosive popularity of 'The Hunger Games,' but that's not the only thing it's got going for it.

Gold, Silver Down on Weak China, EU Data

By Andrew Burger, InvestorPlace Contributor
U.S. weekly unemployment claims continued to fall last week, hitting a four-year low.

Starbucks & Green Mountain Are Still a Team

By Beth Gaston Moon, InvestorPlace Contributor
A new deal ensures that Starbucks' K-Cups will be usable in Green Mountain's new, enhanced machines even as Starbucks preps its own machines for a fall launch.

Memo to Discovery: Don’t Drop Oprah

By Jonathan Berr, InvestorPlace Contributor
Discovery's OWN is losing money, but it shouldn't throw in the towel on Oprah. OWN was hurt by early over-hyping, and many of its problems can be fixed.

McDonald’s CEO Skinner Stepping Down

By Kyle Woodley, Senior Investing Editor, Kiplinger
McDonald's CEO Jim Skinner, who helmed MCD shares to 300% gains since late 2004, is stepping down, leaving the company to Don Thompson.

7 Tech Stocks Challenging Their Dot-Com Price Highs

By Jeff Reeves
The Nasdaq has cleared 3,000, and now some of tech's biggest names are at or above their dot-com highs. Here's who's there -- and who's worth keeping around.

GMCR, Watson Zoom on Deals — Wednesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
Green Mountain gets a much-needed lift from Starbucks, and Watson is buying generic-drug maker Actavis.

Oracle Shares: 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor
This tech giant is on a roll, but it's hardly in the clear. Its focus on smart deals and a rebounding economy do bode well for now.

BAC’s Moynihan Has a Huge Job Ahead

By Susan J. Aluise, Aviation, Auto & Transportation Writer
Fixing the nation’s second-largest bank is a marathon, not a sprint -- and Moynihan has already made big mistakes.

Most Ethical Companies 2012 – 100+ Co.’s with a Conscience

By InvestorPlace Staff
Ethisphere has completed its 2012 ranking of the World's Most Ethical Companies list, including Starbucks, General Electric, Intel, Hasbro and others.

The Battle of the Athletic Apparel Retailers

By Beth Gaston Moon, InvestorPlace Contributor
Nike and Lululemon report earnings Thursday. Who'll win with investors as both of these stocks sit near all-time highs?

China Hits Markets, Materials — Tuesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
The prospect of a cooling China gives Wall Street a chill. But some Chinese solar shares soared after a smaller-than-expected U.S. tariff ruling.

4 Reasons Why Wendy’s Will Never Top McDonald’s

By Beth Gaston Moon, InvestorPlace Contributor
Wendy’s ekes past Burger King to take the No. 2 spot -- but it’s a hollow victory. It can never go beyond that.

Generic Versions of Boniva Approved By the FDA

By InvestorPlace Staff
The FDA approved the first generic versions of osteoporosis drug Boniva, allowing manufacturers like Apotex, Orchid Healthcare and Mylan to make the drug.
Load More Articles